{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:34:39Z","timestamp":1790361279448,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia","award":["RGP-VPP-272"],"award-info":[{"award-number":["RGP-VPP-272"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11010-016-2703-4","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:07:50Z","timestamp":1460678870000},"page":"141-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-\u03baB signaling and IL-8 expression"],"prefix":"10.1007","volume":"416","author":[{"given":"Abdelkader E.","family":"Ashour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atallah F.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairy M. A.","family":"Zoheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad A.","family":"Aboul-Soud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabry M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel R. A.","family":"Abd-Allah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vino T.","family":"Cheryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Rishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"2703_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1008867024545","volume":"10","author":"JG Gurney","year":"1999","unstructured":"Gurney JG, Wall DA, Jukich PJ, Davis FG (1999) The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes Control 10:101\u2013105","journal-title":"Cancer Causes Control"},{"key":"2703_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(04)01424-X","volume":"5","author":"RJ Gilbertson","year":"2004","unstructured":"Gilbertson RJ (2004) Medulloblastoma: signalling a change in treatment. Lancet Oncol 5:209\u2013218. doi: 10.1016\/S1470-2045(04)01424-X","journal-title":"Lancet Oncol"},{"key":"2703_CR3","unstructured":"Research Unit, Oncology Centre, King Faisal Specialist Hospital and Research Centre Tumor Registry Annual Report. 2012. Available from: http:\/\/www.kfshrc.edu.sa\/oncology\/2012_Tumor_Registry_Annual_Report.pdf"},{"key":"2703_CR4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ctrv.2008.09.002","volume":"35","author":"P Fossati","year":"2009","unstructured":"Fossati P, Ricardi U, Orecchia R (2009) Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. Cancer Treat Rev 35:79\u201396. doi: 10.1016\/j.ctrv.2008.09.002","journal-title":"Cancer Treat Rev"},{"key":"2703_CR5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<506::AID-MPO7>3.0.CO;2-X","volume":"31","author":"D Jenkin","year":"1998","unstructured":"Jenkin D, Danjoux C, Greenberg M (1998) Subsequent quality of life for children irradiated for a brain tumor before age 4\u00a0years. Med Pediatr Oncol 31:506\u2013511","journal-title":"Med Pediatr Oncol"},{"key":"2703_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"RW Johnstone","year":"2002","unstructured":"Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153\u2013164","journal-title":"Cell"},{"key":"2703_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1044-579X(02)00131-1","volume":"13","author":"N Ozoren","year":"2003","unstructured":"Ozoren N, El-Deiry WS (2003) Cell surface Death Receptor signaling in normal and cancer cells. Semin Cancer Biol 13:135\u2013147","journal-title":"Semin Cancer Biol"},{"key":"2703_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-4274(02)00422-8","volume":"139","author":"M MacFarlane","year":"2003","unstructured":"MacFarlane M (2003) TRAIL-induced signalling and apoptosis. Toxicol Lett 139:89\u201397","journal-title":"Toxicol Lett"},{"key":"2703_CR9","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","volume":"25","author":"S Fulda","year":"2006","unstructured":"Fulda S, Debatin KM (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798\u20134811. doi: 10.1038\/sj.onc.1209608","journal-title":"Oncogene"},{"key":"2703_CR10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495\u2013516. doi: 10.1080\/01926230701320337","journal-title":"Toxicol Pathol"},{"key":"2703_CR11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1083\/jcb.66.1.188","volume":"66","author":"A Krishan","year":"1975","unstructured":"Krishan A (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66:188\u2013193","journal-title":"J Cell Biol"},{"key":"2703_CR12","doi-asserted-by":"crossref","unstructured":"Anon (2007) All natural (Editorial). Nat Chem Biol 3:351. http:\/\/www.nature.com\/nchembio\/journal\/v3\/n7\/pdf\/nchembio0707-351.pdf","DOI":"10.1038\/nchembio0707-351"},{"key":"2703_CR13","doi-asserted-by":"crossref","unstructured":"Krause J and Tobin G (2013) Discovery, development, and regulation of natural products. Using old solutions to new problems-natural drug discovery in the 21st century 21:3\u201335","DOI":"10.5772\/56424"},{"key":"2703_CR14","first-page":"950","volume":"17","author":"M Khader","year":"2014","unstructured":"Khader M, Eckl PM (2014) Thymoquinone: an emerging natural drug with a wide range of medical applications. Iran J Basic Med Sci 17:950\u2013957","journal-title":"Iran J Basic Med Sci"},{"key":"2703_CR15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ptr.1390","volume":"18","author":"V Hajhashemi","year":"2004","unstructured":"Hajhashemi V, Ghannadi A, Jafarabadi H (2004) Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother Res 18:195\u2013199. doi: 10.1002\/ptr.1390","journal-title":"Phytother Res"},{"key":"2703_CR16","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.5897\/AJB10.638","volume":"9","author":"AM Ahmed","year":"2010","unstructured":"Ahmed AM, Al-Olayan EM, Aboul-Soud MA, Al-Khedhairy AA (2010) The immune enhancer, thymoquinone, and the hope of utilizing the immune system of Aedes caspius against disease agents. Afr J Biotechnol 9:3183\u20133195","journal-title":"Afr J Biotechnol"},{"key":"2703_CR17","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s11033-014-3137-2","volume":"41","author":"E Entok","year":"2014","unstructured":"Entok E, Ustuner MC, Ozbayer C, Tekin N, Akyuz F, Yangi B, Kurt H, Degirmenci I, Gunes HV (2014) Anti-inflammatuar and anti-oxidative effects of Nigella sativa L.: 18FDG-PET imaging of inflammation. Mol Biol Rep 41:2827\u20132834. doi: 10.1007\/s11033-014-3137-2","journal-title":"Mol Biol Rep"},{"key":"2703_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jep.2009.11.001","volume":"127","author":"M Khader","year":"2010","unstructured":"Khader M, Bresgen N, Eckl PM (2010) Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants. J Ethnopharmacol 127:319\u2013324. doi: 10.1016\/j.jep.2009.11.001","journal-title":"J Ethnopharmacol"},{"key":"2703_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5114\/aoms.2013.33329","volume":"11","author":"SA Linjawi","year":"2015","unstructured":"Linjawi SA, Khalil WK, Hassanane MM, Ahmed ES (2015) Evaluation of the protective effect of Nigella sativa extract and its primary active component thymoquinone against DMBA-induced breast cancer in female rats. Arch Med Sci 11:220\u2013229. doi: 10.5114\/aoms.2013.33329","journal-title":"Arch Med Sci"},{"key":"2703_CR20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/01635581.2010.509832","volume":"62","author":"S Banerjee","year":"2010","unstructured":"Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, Sarkar FH, Mohammad RM (2010) Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer 62:938\u2013946. doi: 10.1080\/01635581.2010.509832","journal-title":"Nutr Cancer"},{"key":"2703_CR21","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.14233\/ajchem.2014.16849","volume":"26","author":"R Al-Salahi","year":"2014","unstructured":"Al-Salahi R, Marzouk M, Ashour AE, Alswaidan I (2014) Antitumor activity of 1,2,4-triazolo[1,5-a]quinazolines. Asian J Chem 26:2173\u20132176","journal-title":"Asian J Chem"},{"key":"2703_CR22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M","volume":"24","author":"M Engeland van","year":"1996","unstructured":"van Engeland M, Ramaekers FC, Schutte B, Reutelingsperger CP (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24:131\u2013139. doi: 10.1002\/(SICI)1097-0320(19960601)24:2<131:AID-CYTO5>3.0.CO;2-M","journal-title":"Cytometry"},{"key":"2703_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1097-0320(20000201)39:2<141::AID-CYTO7>3.0.CO;2-O","volume":"39","author":"RG Clarke","year":"2000","unstructured":"Clarke RG, Lund EK, Johnson IT, Pinder AC (2000) Apoptosis can be detected in attached colonic adenocarcinoma HT29 cells using annexin V binding, but not by TUNEL assay or sub-G0 DNA content. Cytometry 39:141\u2013150. doi: 10.1002\/(SICI)1097-0320(20000201)39:2<141:AID-CYTO7","journal-title":"Cytometry"},{"key":"2703_CR24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.cdd.4401225","volume":"10","author":"JE Ricci","year":"2003","unstructured":"Ricci JE, Waterhouse N, Green DR (2003) Mitochondrial functions during cell death, a complex (I\u2013V) dilemma. Cell Death Differ 10:488\u2013492. doi: 10.1038\/sj.cdd.4401225","journal-title":"Cell Death Differ"},{"key":"2703_CR25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.cdd.4401210","volume":"10","author":"AE Bueno-da-Silva","year":"2003","unstructured":"Bueno-da-Silva AE, Brumatti G, Russo FO, Green DR, Amarante-Mendes GP (2003) Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity. Cell Death Differ 10:592\u2013598. doi: 10.1038\/sj.cdd.4401210","journal-title":"Cell Death Differ"},{"key":"2703_CR26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11010-013-1930-1","volume":"389","author":"AE Ashour","year":"2014","unstructured":"Ashour AE, Abd-Allah AR, Korashy HM, Attia SM, Alzahrani AZ, Saquib Q, Bakheet SA, Abdel-Hamied HE, Jamal S, Rishi AK (2014) Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis. Mol Cell Biochem 389:85\u201398. doi: 10.1007\/s11010-013-1930-1","journal-title":"Mol Cell Biochem"},{"key":"2703_CR27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-07-2088","volume":"6","author":"G Sethi","year":"2008","unstructured":"Sethi G, Ahn KS, Aggarwal BB (2008) Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res 6:1059\u20131070. doi: 10.1158\/1541-7786.MCR-07-2088","journal-title":"Mol Cancer Res"},{"key":"2703_CR28","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","volume":"281","author":"CY Wang","year":"1998","unstructured":"Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr (1998) NF-\u03baB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680\u20131683","journal-title":"Science"},{"key":"2703_CR29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/359599a0","volume":"359","author":"AW Murray","year":"1992","unstructured":"Murray AW (1992) Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359:599\u2013604. doi: 10.1038\/359599a0","journal-title":"Nature"},{"key":"2703_CR30","first-page":"107","volume":"22","author":"AM Shoieb","year":"2003","unstructured":"Shoieb AM, Elgayyar M, Dudrick PS, Bell JL, Tithof PK (2003) In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol 22:107\u2013113","journal-title":"Int J Oncol"},{"key":"2703_CR31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2010.12.034","volume":"50","author":"AR Hussain","year":"2011","unstructured":"Hussain AR, Ahmed M, Ahmed S, Manogaran P, Platanias LC, Alvi SN, Al-Kuraya KS, Uddin S (2011) Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma. Free Radic Biol Med 50:978\u2013987. doi: 10.1016\/j.freeradbiomed.2010.12.034","journal-title":"Free Radic Biol Med"},{"key":"2703_CR32","doi-asserted-by":"crossref","first-page":"e12124","DOI":"10.1371\/journal.pone.0012124","volume":"5","author":"RL Gurung","year":"2010","unstructured":"Gurung RL, Lim SN, Khaw AK, Soon JF, Shenoy K, Mohamed Ali S, Jayapal M, Sethu S, Baskar R, Hande MP (2010) Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS One 5:e12124. doi: 10.1371\/journal.pone.0012124","journal-title":"PLoS One"},{"key":"2703_CR33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2741\/E651","volume":"5","author":"EM Dergarabetian","year":"2013","unstructured":"Dergarabetian EM, Ghattass KI, El-Sitt SB, Al-Mismar RM, El-Baba CO, Itani WS, Melhem NM, El-Hajj HA, Bazarbachi AA, Schneider-Stock R, Gali-Muhtasib HU (2013) Thymoquinone induces apoptosis in malignant T-cells via generation of ROS. Front Biosci (Elite Ed) 5:706\u2013719","journal-title":"Front Biosci (Elite Ed)"},{"key":"2703_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bcp.2009.02.009","volume":"78","author":"L Verstrepen","year":"2009","unstructured":"Verstrepen L, Carpentier I, Verhelst K, Beyaert R (2009) ABINs: A20 binding inhibitors of NF-\u03baB and apoptosis signaling. Biochem Pharmacol 78:105\u2013114. doi: 10.1016\/j.bcp.2009.02.009","journal-title":"Biochem Pharmacol"},{"key":"2703_CR35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3892\/or.2012.2165","volume":"29","author":"L Peng","year":"2013","unstructured":"Peng L, Liu A, Shen Y, Xu HZ, Yang SZ, Ying XZ, Liao W, Liu HX, Lin ZQ, Chen QY, Cheng SW, Shen WD (2013) Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-\u03baB pathway. Oncol Rep 29:571\u2013578. doi: 10.3892\/or.2012.2165","journal-title":"Oncol Rep"},{"key":"2703_CR36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2407-11-136","volume":"11","author":"SE Spiller","year":"2011","unstructured":"Spiller SE, Logsdon NJ, Deckard LA, Sontheimer H (2011) Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo. BMC Cancer 11:136. doi: 10.1186\/1471-2407-11-136","journal-title":"BMC Cancer"},{"key":"2703_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-010-0220-y","volume":"101","author":"S Sun","year":"2011","unstructured":"Sun S, Wang Q, Giang A, Cheng C, Soo C, Wang CY, Liau LM, Chiu R (2011) Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-\u03baB. J Neurooncol 101:1\u201314. doi: 10.1007\/s11060-010-0220-y","journal-title":"J Neurooncol"},{"key":"2703_CR38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/10799900252952217","volume":"22","author":"PS Patel","year":"2002","unstructured":"Patel PS, Varney ML, Dave BJ, Singh RK (2002) Regulation of constitutive and induced NF-\u03baB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation. J Interferon Cytokine Res 22:427\u2013435. doi: 10.1089\/10799900252952217","journal-title":"J Interferon Cytokine Res"},{"key":"2703_CR39","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1038\/sj.onc.1204535","volume":"20","author":"S Huang","year":"2001","unstructured":"Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ (2001) Blockade of NF-\u03baB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20:4188\u20134197. doi: 10.1038\/sj.onc.1204535","journal-title":"Oncogene"},{"key":"2703_CR40","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-07-2088","volume":"6","author":"G Sethi","year":"2008","unstructured":"Sethi G, Ahn KS, Aggarwal BB (2008) Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Molecular Cancer Res 6:1059\u20131070. doi: 10.1158\/1541-7786.MCR-07-2088","journal-title":"Molecular Cancer Res"},{"key":"2703_CR41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1476-4598-8-57","volume":"8","author":"RK Singh","year":"2009","unstructured":"Singh RK, Lokeshwar BL (2009) Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs. Mol Cancer 8:57. doi: 10.1186\/1476-4598-8-57","journal-title":"Mol Cancer"},{"key":"2703_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2006.11.014","volume":"56","author":"F Luppi","year":"2007","unstructured":"Luppi F, Longo AM, de Boer WI, Rabe KF, Hiemstra PS (2007) Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 56:25\u201333. doi: 10.1016\/j.lungcan.2006.11.014","journal-title":"Lung Cancer"},{"key":"2703_CR43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/cyto.1999.0518","volume":"12","author":"R Brew","year":"2000","unstructured":"Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78\u201385. doi: 10.1006\/cyto.1999.0518","journal-title":"Cytokine"},{"key":"2703_CR44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.devcel.2011.06.017","volume":"21","author":"JC Martinou","year":"2011","unstructured":"Martinou JC, Youle RJ (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21:92\u2013101. doi: 10.1016\/j.devcel.2011.06.017","journal-title":"Dev Cell"},{"key":"2703_CR45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ijc.21205","volume":"117","author":"MA El-Mahdy","year":"2005","unstructured":"El-Mahdy MA, Zhu Q, Wang QE, Wani G, Wani AA (2005) Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer 117:409\u2013417. doi: 10.1002\/ijc.21205","journal-title":"Int J Cancer"},{"key":"2703_CR46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","volume":"3","author":"M Karin","year":"2002","unstructured":"Karin M, Lin A (2002) NF-\u03baB at the crossroads of life and death. Nat Immunol 3:221\u2013227. doi: 10.1038\/ni0302-221","journal-title":"Nat Immunol"},{"key":"2703_CR47","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35080103","volume":"2","author":"M Holcik","year":"2001","unstructured":"Holcik M, Korneluk RG (2001) XIAP, the guardian angel. Nat Rev Mol Cell Biol 2:550\u2013556. doi: 10.1038\/35080103","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2703_CR48","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1158\/1535-7163.MCT-12-0352","volume":"11","author":"J Keating","year":"2012","unstructured":"Keating J, Tsoli M, Hallahan AR, Ingram WJ, Haber M, Ziegler DS (2012) Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma. Mol Cancer Ther 11:2654\u20132663. doi: 10.1158\/1535-7163.MCT-12-0352","journal-title":"Mol Cancer Ther"},{"key":"2703_CR49","first-page":"6401","volume":"9","author":"C Pingoud-Meier","year":"2003","unstructured":"Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, Grotzer MA (2003) Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin Cancer Res 9:6401\u20136409","journal-title":"Clin Cancer Res"},{"key":"2703_CR50","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.1073\/pnas.94.21.11333","volume":"94","author":"DK Han","year":"1997","unstructured":"Han DK, Chaudhary PM, Wright ME, Friedman C, Trask BJ, Riedel RT, Baskin DG, Schwartz SM, Hood L (1997) MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc Natl Acad Sci USA 94:11333\u201311338","journal-title":"Proc Natl Acad Sci USA"},{"key":"2703_CR51","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V99.11.4079","volume":"99","author":"N Mitsiades","year":"2002","unstructured":"Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP, Anderson KC (2002) Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood 99:4079\u20134086","journal-title":"Blood"},{"key":"2703_CR52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11060-008-9788-x","volume":"93","author":"DG Aguilera","year":"2009","unstructured":"Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, Gopalakrishnan V (2009) Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL. J Neurooncol 93:303\u2013318. doi: 10.1007\/s11060-008-9788-x","journal-title":"J Neurooncol"},{"key":"2703_CR53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0959-8049(01)00355-0","volume":"38","author":"TJ Zuzak","year":"2002","unstructured":"Zuzak TJ, Steinhoff DF, Sutton LN, Phillips PC, Eggert A, Grotzer MA (2002) Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour\/medulloblastoma. Eur J Cancer 38:83\u201391","journal-title":"Eur J Cancer"},{"key":"2703_CR54","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1038\/sj.onc.1203816","volume":"19","author":"MA Grotzer","year":"2000","unstructured":"Grotzer MA, Eggert A, Zuzak TJ, Janss AJ, Marwaha S, Wiewrodt BR, Ikegaki N, Brodeur GM, Phillips PC (2000) Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene 19:4604\u20134610. doi: 10.1038\/sj.onc.1203816","journal-title":"Oncogene"},{"key":"2703_CR55","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.7314\/APJCP.2013.14.10.6159","volume":"14","author":"SS Ulasli","year":"2013","unstructured":"Ulasli SS, Celik S, Gunay E, Ozdemir M, Hazman O, Ozyurek A, Koyuncu T, Unlu M (2013) Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene. Asian Pac J Cancer Prev 14:6159\u20136164","journal-title":"Asian Pac J Cancer Prev"},{"key":"2703_CR56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bcp.2011.05.030","volume":"82","author":"CC Woo","year":"2011","unstructured":"Woo CC, Loo SY, Gee V, Yap CW, Sethi G, Kumar AP, Tan KH (2011) Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-gamma pathway. Biochem Pharmacol 82:464\u2013475. doi: 10.1016\/j.bcp.2011.05.030","journal-title":"Biochem Pharmacol"},{"key":"2703_CR57","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/01635581.2013.878739","volume":"66","author":"KM Sutton","year":"2014","unstructured":"Sutton KM, Greenshields AL, Hoskin DW (2014) Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53. Nutr Cancer 66:408\u2013418. doi: 10.1080\/01635581.2013.878739","journal-title":"Nutr Cancer"},{"key":"2703_CR58","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","volume":"74","author":"LH Boise","year":"1993","unstructured":"Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597\u2013608","journal-title":"Cell"},{"key":"2703_CR59","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.yexcr.2004.03.001","volume":"297","author":"L Lindenboim","year":"2004","unstructured":"Lindenboim L, Schlipf S, Kaufmann T, Borner C, Stein R (2004) Bcl-x(S) induces an NGF-inhibitable cytochrome c release. Exp Cell Res 297:392\u2013403. doi: 10.1016\/j.yexcr.2004.03.001","journal-title":"Exp Cell Res"},{"key":"2703_CR60","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.onc.1203495","volume":"19","author":"L Lindenboim","year":"2000","unstructured":"Lindenboim L, Yuan J, Stein R (2000) Bcl-xS and Bax induce different apoptotic pathways in PC12 cells. Oncogene 19:1783\u20131793. doi: 10.1038\/sj.onc.1203495","journal-title":"Oncogene"},{"key":"2703_CR61","first-page":"2507","volume":"55","author":"VN Sumantran","year":"1995","unstructured":"Sumantran VN, Ealovega MW, Nunez G, Clarke MF, Wicha MS (1995) Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 55:2507\u20132510","journal-title":"Cancer Res"},{"key":"2703_CR62","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.92.24.11024","volume":"92","author":"MF Clarke","year":"1995","unstructured":"Clarke MF, Apel IJ, Benedict MA, Eipers PG, Sumantran V, Gonzalez-Garcia M, Doedens M, Fukunaga N, Davidson B, Dick JE, Minn AJ, Boise LH, Thompson CB, Wicha M, Nunez G (1995) A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci USA 92:11024\u201311028","journal-title":"Proc Natl Acad Sci USA"},{"key":"2703_CR63","author":"R Schneider-Stock","year":"2013","unstructured":"Schneider-Stock R, Fakhoury IH, Zaki AM, El-Baba CO, Gali-Muhtasib HU (2013) Thymoquinone: fifty years of success in the battle against cancer models. Drug Discov Today. doi: 10.1016\/j.drudis.2013.08.021","journal-title":"Drug Discov Today"},{"key":"2703_CR64","doi-asserted-by":"crossref","first-page":"e61342","DOI":"10.1371\/journal.pone.0061342","volume":"8","author":"S Rajput","year":"2013","unstructured":"Rajput S, Kumar BN, Sarkar S, Das S, Azab B, Santhekadur PK, Das SK, Emdad L, Sarkar D, Fisher PB, Mandal M (2013) Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer. PLoS One 8:e61342. doi: 10.1371\/journal.pone.0061342","journal-title":"PLoS One"},{"key":"2703_CR65","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(95)90541-3","volume":"81","author":"M Tewari","year":"1995","unstructured":"Tewari M, Quan LT, O\u2019Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM (1995) Yama\/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801\u2013809","journal-title":"Cell"},{"key":"2703_CR66","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1242\/jcs.114.20.3771","volume":"114","author":"D D\u2019Amours","year":"2001","unstructured":"D\u2019Amours D, Sallmann FR, Dixit VM, Poirier GG (2001) Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci 114:3771\u20133778","journal-title":"J Cell Sci"},{"key":"2703_CR67","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10495-008-0278-6","volume":"13","author":"R Zhang","year":"2008","unstructured":"Zhang R, Humphreys I, Sahu RP, Shi Y, Srivastava SK (2008) In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis 13:1465\u20131478. doi: 10.1007\/s10495-008-0278-6","journal-title":"Apoptosis"},{"key":"2703_CR68","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11060-011-0619-0","volume":"105","author":"S Ohshima-Hosoyama","year":"2011","unstructured":"Ohshima-Hosoyama S, Davare MA, Hosoyama T, Nelon LD, Keller C (2011) Bortezomib stabilizes NOXA and triggers ROS-associated apoptosis in medulloblastoma. J Neurooncol 105:475\u2013483. doi: 10.1007\/s11060-011-0619-0","journal-title":"J Neurooncol"},{"key":"2703_CR69","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","volume":"6","author":"OI Aruoma","year":"1989","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6:593\u2013597","journal-title":"Free Radic Biol Med"},{"key":"2703_CR70","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1038\/sj.onc.1203237","volume":"18","author":"TD Gilmore","year":"1999","unstructured":"Gilmore TD (1999) The Rel\/NF-\u03baB signal transduction pathway: introduction. Oncogene 18:6842\u20136844. doi: 10.1038\/sj.onc.1203237","journal-title":"Oncogene"},{"key":"2703_CR71","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1038\/sj.onc.1206034","volume":"21","author":"S Jin","year":"2002","unstructured":"Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X, Mazzacurati L, Li X, Petrik KL, Rajasekaran B, Wu M, Zhan Q (2002) GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene 21:8696\u20138704. doi: 10.1038\/sj.onc.1206034","journal-title":"Oncogene"},{"key":"2703_CR72","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00001813-200404000-00012","volume":"15","author":"HU Gali-Muhtasib","year":"2004","unstructured":"Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N, Crooks PA (2004) Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 15:389\u2013399","journal-title":"Anticancer Drugs"},{"key":"2703_CR73","doi-asserted-by":"crossref","first-page":"e60540","DOI":"10.1371\/journal.pone.0060540","volume":"8","author":"AR Hussain","year":"2013","unstructured":"Hussain AR, Uddin S, Ahmed M, Al-Dayel F, Bavi PP, Al-Kuraya KS (2013) Phosphorylated IkappaBalpha predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS release. PLoS One 8:e60540. doi: 10.1371\/journal.pone.0060540","journal-title":"PLoS One"},{"key":"2703_CR74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2006.05.046","volume":"543","author":"AA Al-Majed","year":"2006","unstructured":"Al-Majed AA, Al-Omar FA, Nagi MN (2006) Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus. Eur J Pharmacol 543:40\u201347. doi: 10.1016\/j.ejphar.2006.05.046","journal-title":"Eur J Pharmacol"},{"key":"2703_CR75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1078\/0944-7113-00376","volume":"11","author":"H Hosseinzadeh","year":"2004","unstructured":"Hosseinzadeh H, Parvardeh S (2004) Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine 11:56\u201364. doi: 10.1078\/0944-7113-00376","journal-title":"Phytomedicine"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2703-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-016-2703-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2703-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T18:09:35Z","timestamp":1655489375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-016-2703-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":75,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2703"],"URL":"https:\/\/doi.org\/10.1007\/s11010-016-2703-4","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]}}}